Drug Profile
DMP 323
Alternative Names: DM 323; XM 323Latest Information Update: 16 Dec 1996
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 16 Dec 1996 DM 323 now called DMP 323
- 14 Oct 1994 Discontinued-I for HIV infections treatment in USA (PO)